Hengeler Mueller | View firm profile
LEO Pharma
completes the acquisition of Bayer’s prescription dermatology business. The
transaction includes the product rights for Bayer’s global prescription
dermatology business with the exception of Afghanistan and Pakistan, a
production facility in Segrate, Italy, and a total of 347 employees who will
join LEO Pharma in addition to the employees who joined from the United States
last year.
Hengeler
Mueller advised Bayer on the transaction. The team was led by partners Matthias
Hentzen and Christian Wentrup (both Corporate/M&A) and included partner
Thorsten Mäger (Antitrust) (all Düsseldorf), counsel Gunther Wagner (Tax,
Munich) as well as associates Florian Hassner, Gerrit Forst, Daniel Doetsch,
and Richard Suermann (all Corporate/M&A, Düsseldorf).